First case of a rare form of autosomal dominant axonal hereditary motor and sensory polyneuropathy caused by a mutation c.754C>T, p.Arg252Trp in the MORC2 gene with late onset (HMSN type 2Z).

Authors

DOI:

https://doi.org/10.5281/zenodo.16884098

Keywords:

CMT, HMSN, CPK, MORC2,

Abstract

Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathies (HMSN) is a group of inherited motor and sensory peripheral neuropathies and the most common inherited neuromuscular disorder. HMSN was first described as a clinical entity in 1886 by physicians Jean-Marie Charcot, Pierre Marie, and Howard Henry Tooth, who called it "progressive muscular atrophy." HMSN is heterogeneous in its clinical, electrophysiological, genetic, and pathological features. We present a 53-year-old man with a 20-year history of progressive weakness of the lower and upper limbs and an unsteady gait. On admission, physical examination revealed bilateral weakness and weakness of the distal muscles of the upper and lower limbs, pes planus, and elevated serum creatine phosphokinase (CPK). Electromyography showed axonal neuropathy affecting both the upper and lower limbs. Molecular genetic testing identified a pathogenic variant p.Arg252Trp in the MORC2 gene.

Therefore, these clinical and genetic findings suggest a diagnosis of hereditary motor and sensory neuropathy type 2Z.

References

Ando M, Okamoto Y, Yoshimura A, Yuan JH, Hiramatsu Y, Higuchi Y, Hashiguchi A, Mitsui J, Ishiura H, Fukumura S, Matsushima M, Ochi N, Tsugawa J, Morishita S, Tsuji S, Takashima H (2017). Clinical and mutational spectrum of Charcot-Marie-Tooth disease type 2Z caused by MORC2 variants in Japan. Eur J Neurol 24:1274–1282.

Guillen Sacoto MJ, Tchasovnikarova IA, Torti E, Forster C, Andrew EH, Anselm I, Baranano KW, Briere LC, Cohen JS, Craigen WJ, Cytrynbaum C, Ekhilevitch N, Elrick MJ, Fatemi A, Fraser JL, Gallagher RC, Guerin A, Haynes D, High FA, Inglese CN, Kiss C, Koenig MK, Krier J, Lindstrom K, Marble M, Meddaugh H, Moran ES, Morel CF, Mu W, Muller EA 2nd, Nance J, Natowicz MR, Numis AL, Ostrem B, Pappas J, Stafstrom CE, Streff H, Sweetser DA, Szybowska M, Undiagnosed Diseases N, Walker MA, Wang W, Weiss K, Weksberg R, Wheeler PG, Yoon G, Kingston RE, Juusola J (2020). De novo variants in the ATPase module of MORC2 cause a neurodevelopmental disorder with growth retardation and variable craniofacial dysmorphism. Am J Hum Genet 107:352–363.

Sancho P, Bartesaghi L, Miossec O, Garcia-Garcia F, Ramirez-Jimenez L, Siddell A, Akesson E, Hedlund E, Lassuthova P, Pascual-Pascual SI, Sevilla T, Kennerson M, Lupo V, Chrast R, Espinos C (2019). Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations. Hum Mol Genet 28:1629–1644.

Schottmann G, Wagner C, Seifert F, Stenzel W, Schuelke M (2016). MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis. Brain 139:e70.

Sevilla T, Lupo V, Martinez-Rubio D, Sancho P, Sivera R, Chumillas MJ, Garcia-Romero M, PascualPascual SI, Muelas N, Dopazo J, Vilchez JJ, Palau F, Espinos C (2016). Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Brain 139:62–72.

Sivera, R., Lupo, V., Frasquet, M., Argente‐Escrig, H., Alonso‐Pérez, J., Díaz‐Manera, J., Querol, L., Del Mar García‐Romero, M., Pascual, S. I., García‐Sobrino, T., Paradas, C., Vázquez‐Costa, J. F., Muelas, N., Millet, E., Vílchez, J. J., Espinós, C., & Sevilla, T. (2021). Charcot–Marie–Tooth disease due to MORC2 mutations in Spain. European Journal of Neurology, 28(9), 3001–3011.

Zanni G, Nardella M, Niceta M, Bellacchio E, Ciolfi A, Di Capua M, D’Arrigo S, Tartaglia M, Bertini E (2017). De novo T362R mutation in MORC2 causes early onset cerebellar ataxia, axonal polyneuropathy and nocturnal hypoventilation. Eur Paed Neurol 21:e236.

Published

30.06.2025

How to Cite

Asenov, O., Chamova, T., Jordanova, A., & Tournev, I. (2025). First case of a rare form of autosomal dominant axonal hereditary motor and sensory polyneuropathy caused by a mutation c.754C>T, p.Arg252Trp in the MORC2 gene with late onset (HMSN type 2Z). Bulgarian Neurology, 26(1), 43–46. https://doi.org/10.5281/zenodo.16884098

ARK